MarketInOut Stock Screener Log In | Sign Up
 

Hikma Pharmaceuticals Plc

OTC • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 08/17/2026
Hikma Pharmaceuticals Plc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeOTC
Market Capitalization4,593.06 mln
Float146 mln
Earnings Date02/26/2027

EPS

1.76
Decent

P / E

12.61
Fair value

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.48
Borderline

Relative Strength

75 / 100
Strongly outperforming

Debt / Equity

0.78
Moderate leverage

Business Description

Hikma Pharmaceuticals is a global medicine maker founded in 1978 and based in London. The company produces and sells a wide range of drugs across hospitals and retail pharmacies, covering areas such as cancer treatment, respiratory conditions, and pain relief. Its products reach customers across North America, Europe, the Middle East, North Africa, and beyond.

Key Fundamentals

EPS1.76
P/E12.61
ROE15.25
RPS15.64
ROIC9.98
ROA6.84
Interest Cover6.19
EBITDA, mln864
EV / EBITDA7.09
EV / EBIT10.02
Revenue, mln3,419
EV / Revenue1.79

Financial Strength

Altman Z-Score2.7
Piotroski F-Score 5 / 9
Beneish M-Score-2.48
Price to Graham Number1.16
Shiller PE Ratio20.34

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 4.36% 73 / 100   
1 Month 30.78% 91 / 100   
2 Months -5.22% 42 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us